← Back to Search

Bromfenac 0.09% for Acute Pain

Phase 4
Waitlist Available
Research Sponsored by Wills Eye
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will be asked in the office for their pain rating 5 minutes after injection
Awards & highlights

Study Summary

The purpose of this prospective interventional study is to compare post-intravitreal injection pain between eyes receiving topical bromfenac versus artificial tears as an analgesic after intravitreal injection.

Eligible Conditions
  • Acute Pain
  • Intravitreal Injections
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will be asked in the office for their pain rating 5 minutes after injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and patients will be asked in the office for their pain rating 5 minutes after injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in post-injection pain at 24 hours using the Short Form McGill Pain Questionnaire Present Pain Intensity score.
Change in post-injection pain at 5 minutes using the Short Form McGill Pain Questionnaire Present Pain Intensity score
Change in post-injection pain at 5 minutes using the Wong-Baker Faces pain scale
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bromfenac 0.09%Experimental Treatment1 Intervention
At the time of the injection, the first eye will be randomized to a drop of artificial tear or bromfenac 0.09% and the second eye will receive the other agent.
Group II: Artificial TearPlacebo Group1 Intervention
At the time of the injection, the first eye will be randomized to a drop of artificial tear or bromfenac 0.09% and the second eye will receive the other agent.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Use of bromfenac 0.09% to reduce intravitreal injection pain
2021
Completed Phase 4
~100

Find a Location

Who is running the clinical trial?

Wills EyeLead Sponsor
79 Previous Clinical Trials
10,339 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
Sunir Garg MD 2021. "Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06130384.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top